Stefanou D - Search Results

1

Expression of vascular endothelial growth factor and the adhesion molecule E-cadherin in non-small cell lung cancer.

Stefanou D, Goussia AC, Arkoumani E, Agnantis NJ. Stefanou D, et al. Anticancer Res. 2003 Nov-Dec;23(6C):4715-20. Anticancer Res. 2003. PMID: 14981918

2

Expression of vascular endothelial growth factor (VEGF) and association with microvessel density in benign prostatic hyperplasia and prostate cancer.

Stefanou D, Batistatou A, Kamina S, Arkoumani E, Papachristou DJ, Agnantis NJ. Stefanou D, et al. In Vivo. 2004 Mar-Apr;18(2):155-60. In Vivo. 2004. PMID: 15113042 Free article.

3

Immunohistochemical expression of vascular endothelial growth factor (VEGF) and C-KIT in cutaneous melanocytic lesions.

Stefanou D, Batistatou A, Zioga A, Arkoumani E, Papachristou DJ, Agnantis NJ. Stefanou D, et al. Int J Surg Pathol. 2004 Apr;12(2):133-8. doi: 10.1177/106689690401200206. Int J Surg Pathol. 2004. PMID: 15173918

4

COX-2 expression correlates with VEGF-C and lymph node metastases in patients with head and neck squamous cell carcinoma.

Kyzas PA, Stefanou D, Agnantis NJ. Kyzas PA, et al. Among authors: stefanou d. Mod Pathol. 2005 Jan;18(1):153-60. doi: 10.1038/modpathol.3800244. Mod Pathol. 2005. PMID: 15272284 Free article.

5

Potential autocrine function of vascular endothelial growth factor in head and neck cancer via vascular endothelial growth factor receptor-2.

Kyzas PA, Stefanou D, Batistatou A, Agnantis NJ. Kyzas PA, et al. Among authors: stefanou d. Mod Pathol. 2005 Apr;18(4):485-94. doi: 10.1038/modpathol.3800295. Mod Pathol. 2005. PMID: 15475932 Free article.

6

Hypoxia-induced tumor angiogenic pathway in head and neck cancer: an in vivo study.

Kyzas PA, Stefanou D, Batistatou A, Agnantis NJ. Kyzas PA, et al. Among authors: stefanou d. Cancer Lett. 2005 Jul 28;225(2):297-304. doi: 10.1016/j.canlet.2004.11.060. Epub 2005 Jan 18. Cancer Lett. 2005. PMID: 15978334

7

Prognostic significance of VEGF immunohistochemical expression and tumor angiogenesis in head and neck squamous cell carcinoma.

Kyzas PA, Stefanou D, Batistatou A, Agnantis NJ. Kyzas PA, et al. Among authors: stefanou d. J Cancer Res Clin Oncol. 2005 Sep;131(9):624-30. doi: 10.1007/s00432-005-0003-6. Epub 2005 Oct 20. J Cancer Res Clin Oncol. 2005. PMID: 16044346

8

Expression of vascular endothelial growth factor and its receptor, KDR/Flk-1, in soft tissue sarcomas.

Pakos EE, Goussia AC, Tsekeris PG, Papachristou DJ, Stefanou D, Agnantis NJ. Pakos EE, et al. Among authors: stefanou d. Anticancer Res. 2005 Sep-Oct;25(5):3591-6. Anticancer Res. 2005. PMID: 16101185 Free article.

9

Endoglin (CD105) as a prognostic factor in head and neck squamous cell carcinoma.

Kyzas PA, Agnantis NJ, Stefanou D. Kyzas PA, et al. Among authors: stefanou d. Virchows Arch. 2006 Jun;448(6):768-75. doi: 10.1007/s00428-006-0195-4. Epub 2006 Apr 13. Virchows Arch. 2006. PMID: 16612622

10

Prognostic impact of lymphangiogenesis and lymphatic invasion (CD105 expression) in small cell lung carcinoma.

Hardavella G, Arkoumani E, Dalavanga Y, Galanis P, Agnantis NJ, Constantopoulos S, Stefanou D. Hardavella G, et al. Among authors: stefanou d. Anticancer Res. 2008 Jan-Feb;28(1A):343-7. Anticancer Res. 2008. PMID: 18383867 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

135 results

Search Page

Filters